By measuring oxygen extraction fraction (OEF) in the brain tissue in all conditions of rest and functional activity, important information of brain functionality in both health and disease could be achieved (
1). In addition, the human brain is at most about 2% of the whole body weight, but it nearly consumes 20% of the body’s oxygen supply (
2).
Developing a reliable technique for whole brain oxygen mapping could lead to a better understanding of normal physiology in any condition which could also be of great help in situations with disturbance in oxygen supply. Previous studies have shown that hypoxia (lack of oxygen in tissue) in tumors could affect the response to therapies, metastasis, aggressiveness and local recurrence and thus aggravate the overall prognosis (
3).
To calculate oxygen consumption, several parameters have been introduced. The most important ones are cerebral metabolic rate of oxygen consumption (CMRO2) and oxygen extraction fraction (OEF). OEF could be defined as the fraction of oxygen that is removed from the blood flowing through by the brain tissue (
1,
2). It is extremely uniform in baseline condition (resting state which is the awake state with eyes closed).
As the brain uses most of the energy budget in the baseline condition and activity represents only a small increasing change, understanding its functionality could lead to understanding of the normal performance of the human which is essential for baseline abnormality due to diseases such as stroke and Alzheimer. For instance, in patients with cerebrovascular diseases, OEF has been an accurate predictor in later strokes (
4). Also, other brain disorders, such as Parkinson, Alzheimer and Huntington disease, and multisystem atrophy, contain changes in cerebral oxygen metabolism (
3).
To have an acceptable oxygen mapping method, some standards should be considered, such as sufficient temporal and spatial resolution, noninvasiveness, quantification of oxygen level, no radiation exposure, high safety and availability in all clinics. Currently none of the in vivo methods contains all of these requirements (
3).
The gold standard for OEF imaging is positron emission tomography (PET) that involves a sequence of three scans with injection of
15O or
18F that is about 46 min and meanwhile the patient is exposed to a radiation dose of 8300MBq (
5).
PET imaging has several disadvantages that limit its use. It is not widely available and it requires radioactive isotope at the start of the cyclotron which is why it is not repeatable in the same subject. It also has low resolution, long imaging time, and it is expensive.
The development of blood oxygen level dependent (BOLD) MRI by Ogawa et al. created a new tendency in the noninvasive study of brain hemodynamic. BOLD imaging is based on the fact that deoxygenated and oxygenated bloods have different magnetic susceptibilities and the magnetic susceptibility of the deoxygenated blood is similar to that of the tissue. In theoretical models of BOLD contrast, BOLD signal is related to hemodynamic parameters such as deoxyhemoglobin concentration, deoxyhemoglobin containing blood volume (DBV), CMRO
2 and OEF (
1).
In comparison with PET imaging, MR imaging is safe, noninvasive, widely available in clinics, repeatable and cheap. Also with a proper method, all images could be acquired within a short time and it could be done with all standard MRI scanners.
After the development of BOLD imaging in 1990, several methods have been proposed for OEF measurements in whole brain or a single vein which could give some valuable information in normal cases but in the presence of neuronal abnormality or tumors, it can not provide local information. Methods such as An and Lin (2000) (
6), Lu and Zijl (2005) (
7), Lu and Ge (2008) (
8), Huppert (2009) (
9), Xu (2009) (
10), Jain (2010) (
11) and Qin (2011) (
12) could be placed in this category and TRUST and VASO methods are the most known of them.
Some other methods for OEF measurements need primary assumption of cerebral blood volume (CBV) and tried to show the OEF as a map in a limited part of the brain. Studies conducted by Domsch and Mie (2001) (
13), He and Yablonskiy (2007, 2008) (
1,
4), and Bolar (2011) (
14) are based on such procedures.
The latest methods that have been developed for OEF measurement are based on a combination of hyperoxic and hypercapnic stimulus while acquiring ASL data. Gauthier and Hoge (2012) (
15) and Bulte (2012) (
5) where the first group that used these methods. In the following years (2013, 2016), wise et al. (
16,
17) made some improvement to these methods and gained more accurate results for OEF.